Structural chromosome abnormalities associated with obesity: Report of four new subjects and review of literature

Current Genomics

Volumn 12, Issue 3, 2011, Pages 190-203

  Dasouki, Majed J ^a   Youngs, Erin L ^a   Hovanes, Karine ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b CombiMatrix Diagnostics ^*  (United States)

Author keywords

Acgh; Chromosome; Cnv; Deletion; Duplication; Fluorescent in situ hybridization; Obesity; Translocation

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CASE REPORT; CHILD; CHILDHOOD DISEASE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; HAPPY PUPPET SYNDROME; HUMAN; KIDNEY CYST; MALE; OBESITY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRADER WILLI SYNDROME; SCHOOL CHILD; STRUCTURAL CHROMOSOME ABERRATION; URIC ACID BLOOD LEVEL; WEIGHT GAIN;

EID: 79956274937     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920211795677930     Document Type: Article

References (105)

1. Bouchard, C.; Perusse, L. Current status of the human obesity gene map. Obes. Res., 1996, 4, 81-90.
2. Rankinen, T; Zuberi, A; Chagnon, Y.C; Weisnagel, S.J; Argyropoulos, G.; Walts, B.; Pérusse, L.; Bouchard, C. The Human Obesity Gene Map: The 2005 Update. Obesity, 2006, 14, 529-644.
3. Yu, S.; Kielt, M.; Stegner, A.L.; Kibiryeva, N.; Bittel, D.C.; Cooley, L.D. Quantitative real-time PCR for the verification of genomic imbalances detected by microarray-based comparative genomic hybridization. Genet. Test Mol. Biomarkers, 2009, 13, 751-760.
4. Yu, S.; Bittel, D.C.; Kibiryeva, N.; Zwick, D.L.; Cooley, L.D. Validation of the Agilent 244K oligonucleotide array-based comparative genomic hybridization platform for clinical cytogenetic diagnosis. Am. J. Clin. Pathol., 2009, 132, 349-360.
5. Stankiewicz, P.; Lupski, J.R. Structural variation in the human genome and its role in disease. Annu. Rev. Med., 2010, 61, 437-455.
6. Kurotaki, N.; Shen, J.J.; Touyama, M.; Kondoh, T.; Visser, R.; Ozaki, T.; Nishimoto, J.; Shiihara, T.; Uetake, K.; Makita, Y.; Harada, N.; Raskin, S.; Brown, C.W.; Höglund, P.; Okamoto, N.; Lupski, J. R. Phenotypic consequences of genetic variation at hemizygous alleles: Sotos syndrome is a contiguous gene syndrome incorporating coagulation factor twelve (FXII) deficiency. Genet. Med., 2005, 7, 479-483.
7. Lupski, J.R.; Stankiewicz, P. Genomic disorder mechanisms elucidated by breakpoint analysis of 17p rearrangements. PLoS Genet., 2005, 1:e49.
8. Goss, P.W.; Voullaire, L.; Gardner, R.J. Duplication 10q22.1-q25.1 due to intrachromosomal insertion: A second case. Ann. Genet., 1998, 41, 161-163.
9. Han, J.Y.; Kim, K.H.; Jun, H.J.; Je, G.H.; Glotzbach, C.D.; Shaffer, L.G. Partial trisomy of chromosome 10(q22-q24) due to maternal insertional translocation (15;10). Am. J. Med. Genet. A, 2004, 131, 190-193.
10. Dufke, A.; Singer, S.; Borell-Kost, S.; Stotter, M.; Pflumm, D.A.; Mau-Holzmann, U.A.; Starke, H.; Mrasek, K.; Enders, H. De novo structural chromosomal imbalances: Molecular cytogenetic characterization of partial trisomies. Cytogenet. Genome Res., 2006, 114, 342-350.
11. Erdogan, F.; Belloso, J.M.; Gabau, E.; Ajbro, K.D.; Guitart, M.; Ropers, H.H.; Tommerup, N.; Ullmann, R.; Tümer, Z.; Larsen, L.A. Fine mapping of a de novo interstitial 10q22-q23 duplication in a patient with congenital heart disease and microcephaly. Eur. J. Med. Genet., 2008, 51, 81-86.
12. Alliman, S.; Coppinger, J.; Marcadier, J.; Thiese, H.; Brock, P.; Shafer, S.; Weaver, C.; Asamoah, A.; Leppig, K.; Dyack, S.; Morash, B.; Schultz, R.; Torchia, B.S.; Lamb, A.N.; Bejjani, B.A. Clinical and molecular characterization of individuals with recurrent genomic disorder at 10q22.3q23.2. Clin. Genet., 2010, 78, 162-168.
13. van Bon, B.W.M.; Balciuniene, J.; Fruhman, G.; Sreenath Nagamani, S.C.; Broome, D.L.; Cameron, E.; Martinet, D.; Roulet, E.; Jacquemont, S.; Beckmann, J.S.; Irons, M.; Potocki, L.; Lee, B.; Cheung, S.W.; Patel, A.; Bellini, M.; Selicorni, A.; Ciccone, R.; Silengo, M.; Vetro, A.; Knoers, N.V.; de Leeuw, N.; Pfundt, R.; Wolf, B.; Jira, P.; Aradhya, S.; Stankiewicz, P.; Brunner, H.G.; Zuffardi, O.; Selleck, S.B.; Lupski, J.R.; and de Vries, B.B.A. The phenotype of recurrent 10q22q23 deletions and duplications. Eur. J. Hum. Genet., 2011, 19, 400-408.
14. Dong, C.; Wang, S.; Li, W.; Li, D.; Zhao, H.; Price, R. Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am. J. Hum. Genet., 2003, 72, 115-124.
15. Bell, C.; Benzinou, M.; Siddiq, A.; Lecoeur, C.; Dina, C.; Lemainque, A.; Clément, K.; Basdevant, A.; Guy-Grand, B.; Mein, C.A.; Meyre, D.; Froguel, P. Genome-wide linkage analysis for severe obesity in French Caucasians finds significant susceptibility locus on chromosome 19q. Diabetes, 2004, 53, 1857-1865.
16. Walters, R.G.; Jacquemont, S.; Valsesia, A.; de Smith, A.J.; Martinet, D.; Andersson, J.; Falchi, M.; Chen, F.; Andrieux, J.; Lobbens, S.; Delobel, B.; Stutzmann, F.; El-Sayed Moustafa, J.S.; Chèvre, J.C.; Lecoeur, C.; Vatin, V.; Bouquillon, S.; Buxton, J.L.; Boute, O.; Holder-Espinasse, M.; Cuisset, J.M.; Lemaitre, M.P.; Ambresin, A.E.; Brioschi, A.; Gaillard, M.; Giusti, V.; Fellmann, F.; Ferrarini, A.; Hadjikhani, N.; Campion, D.; Guilmatre, A.; Goldenberg, A.; Calmels, N.; Mandel, J. L.; LeCaignec, C.; David, A.; Isidor, B.; Cordier, M.P.; Dupuis-Girod, S.; Labalme, A.; Sanlaville, D.; Béri-Dexheimer, M.; Jonveaux, P.; Leheup, B.; Ounap, K.; Bochukova, E.G.; Henning, E.; Keogh, J.; Ellis, R.J.; Macdermot, K.D.; van Haelst M.M.;Vincent-Delorme, C.; Plessis, G.; Touraine, R; Philippe, A.; Malan, V.; Mathieu-Dramard, M.; Chiesa, J; Blaumeiser, B; Kooy, R.F.; Caiazzo, R.; Pigeyre, M.; Balkau, B; Sladek, R; Bergmann, S.; Mooser, V.; Waterworth, D; Reymond, A.; Vollenweider, P.; Waeber, G.; Kurg, A.; Palta, P.; Esko, T.; Metspalu, A.; Nelis, M.; Elliott, P.; Hartikainen, A.L; McCarthy, M.I.; Peltonen, L.; Carlsson, L.; Jacobson, P.; Sjöström, L.; Huang, N.; Hurles, M.E.; O'Rahilly, S.; Farooqi, I.S.; Männik, K.; Jarvelin, M.R.; Pattou, F.; Meyre, D.; Walley, A.J.; Coin, L.J.; Blakemore, A.I.; Froguel, P.; Beckmann, J.S. A new highlypenetrant form of obesity due to deletions on chromosome16p11.2. Nature, 2010, 463, 671-675.
17. Bochukova, E.G.; Huang, N.; Keogh, J.; Henning, E.; Purmann, C.; Blaszczyk, K.; Saeed, S.; Hamilton-Shield, J.; Clayton-Smith, J.; O'Rahilly, S.; Hurles, M.E.; Farooqi, I.S. Large, rarechromosomal deletions associated with severe early-onsetobesity. Nature, 2010, 463, 666-670.
18. Bachmann-Gagescu, R.; Mefford, H.C.; Cowan, C.; Glew, G. M.; Hing, A.V.; Wallace, S.; Bader, P.I.; Hamati, A.; Reitnauer, P.J.; Smith, R.; Stockton, D.W.; Muhle, H.; Helbig, I.; Eichler, E.E.; Ballif, B.C.; Rosenfeld, J.; Tsuchiya, K.D. Recurrent 200-kbdeletions of 16p11.2 that include the SH2B1 gene are associated withdevelopmental delay and obesity. Genet. Med., 2010, 12, 641-647.
19. Ren, D.; Zhou, Y.; Morris, D.; Li, M.; Li. Z; Rui, L. NeuronalSH2B1 is essential for controlling energy and glucose homeostasis. J.Clin. Invest., 2007, 117, 397-406.
20. Coffee, B.; Ikeda, M.; Budimirovic, D.B.; Hjelm, L.N.; Kaufmann, W.E.; Warren, S.T. Research review mosaic FMR1 deletion causesfragile x syndrome and can lead to molecular misdiagnosis: A casereport and review of the literature. Am. J. Med. Genet. Part A, 2008,146A, 1358-1367.
21. Hirst, M.; Grewal, P.; Flannery, A.; Slatter, R.; Maher, E.; Barton, D.; Fryns, J.P.; Davies, K. Two new cases of FMR1 deletion associatedwith mental impairment. Am. J. Hum. Genet., 1995, 56, 67-74.
22. Quan, F.; Zonana, J.; Gunter, K.; Peterson, K.L.; Magenis, R.E.; Popovich, B.W. An atypical case of fragile X syndrome caused by adeletion that includes the FMR1 gene. Am. J. Hum. Genet., 1995, 56,1042-1051.
23. Quan, F.; Grompe, M.; Jakobs, P.; Popovich, B.W. Spontaneousdeletion in the FMR1 gene in a patient with fragile X syndrome andcherubism. Hum. Mol. Genet., 1995, 4, 1681-1684.
24. Probst, F.J.; Roeder, E.R.; Enciso, V.B.; Ou, Z.; Cooper, M.L.; Eng, P.; Li, J.; Gu, Y.; Stratton, R.F.; Chinault, A.C.; Shaw, C.A.; Sutton, V.R.; Cheung, S.W.; Nelson, D.L. Chromosomal microarray analysis(CMA) detects a large X chromosome deletion including FMR1,FMR2, and IDS in a female patient with mental retardation. Am. J.Med. Genet. A, 2007, 143A, 1358-1365.
25. Wolff, D.J.; Gustashaw, K.M.; Zurcher, V.; Ko, L.; White, W.; Weiss, L.; Van Dyke, D.L.; Schwartz, S.; Willard, H.F. Deletions inXq26.3-q27.3 including FMR1 result in a severe phenotype in a maleand variable phenotypes in females depending upon the Xinactivation pattern. Hum. Genet., 1997, 100, 256-261.
26. Parvari, R.; Mumm, S.; Galil, A.; Manor, E.; Bar-David, Y.; Carmi, R. Deletion of 8.5 Mb, including the FMR1 gene, in a male with thefragile X syndrome phenotype and overgrowth. Am. J. Med. Genet.,1999, 83, 302-307.
27. Meijer, H.; de Graaff, E.; Merckx, D.M.; Jongbloed, R.J.; de Die-Smulders, C.E.; Engelen, J.J.; Fryns, J.P.; Curfs, P.M.; Oostra, B.A.A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 genecauses the clinical phenotype of the fragile X syndrome. Hum. Mol.Genet., 1994, 3, 615-620.
28. Moore, S.J.; Strain, L.; Cole, G.F.; Miedzybrodzka, Z.; Kelly, K.F.; Dean, J.C. Fragile X syndrome with FMR1 and FMR2 deletion. J.Med. Genet., 1999, 36, 565-566.
29. de Vries, B.B.; Fryns, J.P.; Butler, M.G.; Canzian, F.; Wesby-vanSwaay, E.; van Hemel, J.O.; Oostra, B.A.; Halley, D.J.; Niermeijer, M.F. Clinical and molecular studies in fragile X patients with aPrader-Willi-like phenotype. J. Med. Genet., 1993, 30, 761-766.
30. Tümer, Z.; Wolff, D.; Silahtaroglu, A.N.; Orum, A.; Brøndum-Nielsen, K. Characterization of a supernumerary small marker Xchromosome in two females with similar phenotypes. Am. J. Med.Genet., 1998, 76, 45-50.
31. Monaghan, K.G.; Van Dyke, D.L.; Feldman, G.L. Prader-Willi-likesyndrome in a patient with an Xq23q25 duplication. Am. J. Med.Genet., 1998, 80, 227-231.
32. Tzschach, A.; Chen, W.; Erdogan, F.; Hoeller, A.; Ropers, H.H.; Castellan, C.; Ullmann, R.; Schinzel, A. Characterization ofinterstitial Xp duplications in two families by tiling path array CGH.Am. J. Med. Genet. A, 2008, 146A, 197-203.
33. Gabbett, M.T.; Peters, G.B.; Carmichael, J.M.; Darmanian, A.P.; Collins, F.A. Prader-Willi syndrome phenocopy due to duplication ofXq21.1-q21.31, with array CGH of the critical region. Clin. Genet.,2008, 73, 353-359.
34. Florez, L.; Anderson, M.; Lacassie, Y. De novo paracentric inversion(X)(q26q28) with features mimicking Prader-Willi syndrome. Am. J.Med. Genet. A, 2003, 121A, 60-64.
35. Talaban, R.; Sellick, G.S.; Spendlove, H.E.; Howell, R.; King, C.; Reckless, J.; Newbury-Ecob, R.; Houlston, R.S. Inherited pericentricinversion (X)(p11.4q11.2) associated with delayed puberty andobesity in two brothers. Cytogenet. Genome Res., 2005, 109, 480-484.
36. Balci, S.; Unal, A.; Engiz, O.; Aktas, D.; Liehr, T.; Gross, M.; Mrasek, K.; Saygi, S. Bilateral periventricular nodular heterotopia, severe learning disability, and epilepsy in a male patient with46,XY,der(19)t(X;19)(q11.1-11.2;p13.3). Dev. Med. ChildNeurol., 2007, 49, 219-224.
37. Eugster, E.A.; Berry, S.A.; Hirsch, B. Mosaicism for deletion1p36.33 in a patient with obesity and hyperphagia. Am. J. Med.Genet., 1997, 70, 409-412.
38. Slavotinek, A.; Shaffer, L.G.; Shapira, S.K. Monosomy 1p36. J.Med. Genet., 1999, 36, 657-663.
39. Finelli, P.; Giardino, D.; Russo, S.; Gottardi, G.; Cogliati, F.; Grugni, G.; Natacci, F.; Larizza, L. Refined FISHcharacterization of a de novo 1p22-p36.2 paracentric inversionand associated 1p21-22 deletion in a patient with signs of 1p36microdeletion syndrome. Am. J. Med. Genet., 2001, 99, 308-313.
40. Neumann, L.M.; Polster, T.; Spantzel, T.; Bartsch, O.Unexpected death of a 12 year old boy with monosomy 1p36.Genet. Couns., 2004, 15, 19-26.
41. D'Angelo, C.S.; Da Paz, J.A.; Kim, C.A.; Bertola, D.R.; Castro, C.I.; Varela, M.C.; Koiffmann, C.P. Prader-Willi-like phenotype:investigation of 1p36 deletion in 41 patients with delayedpsychomotor development, hypotonia, obesity and/orhyperphagia, learning disabilities and behavioral problems. Eur.J. Med. Genet., 2006, 49, 451-460.
42. Haimi, M.; Iancu, T.C.; Shaffer, L.G.; Lerner, A. Severelysosomal storage disease of liver in del(1)(p36): A newpresentation. Eur. J. Med. Genet., 2010, [Epub ahead of print].
43. D'Angelo, C.S.; Kohl, I.; Varela, M.C.; de Castro, C.I.; Kim, C.A.; Bertola, D.R.; Lourenço, C.M.; Koiffmann, C.P. Extendingthe phenotype of monosomy 1p36 syndrome and mapping of acritical region for obesity and hyperphagia. Am. J. Med. Genet.A, 2010, 152A, 102-110.
44. Tsuyusaki, Y.; Yoshihashi, H.; Furuya, N.; Adachi, M.; Osaka, H.; Yamamoto, K.; Kurosawa, K. 1p36 deletion syndromeassociated with Prader-Willi-like phenotype. Pediatr. Int., 2010,52, 547-550.
45. Phelan, M.C.; Rogers, R.C.; Clarkson, K.B.; Bowyer, F.P.; Levine, M.A.; Estabrooks, L.L.; Severson, M.C.; Dobyns, W.B. Albright hereditary osteodystrophy and del(2) (q37.3) in fourunrelated individuals. Am. J. Med. Genet., 1995, 58, 1-7.
46. Giardino, D.; Finelli, P.; Gottardi, G.; De Canal, G.; DellaMonica, M.; Lonardo, F.; Scarano, G.; Larizza, L. Narrowing thecandidate region of Albright hereditary osteodystrophy-likesyndrome by deletion mapping in a patient with an unbalancedcryptic translocation t(2;6)(q37.3;q26). Am. J. Med. Genet. A,2003, 122A, 261-265.
47. Fernández-Rebollo, E.; Pérez, O.; Martinez-Bouzas, C.; Cotarelo-Pérez, M.C.; Garin, I.; Ruibal, J.L.; Pérez-Nanclares, G.; Castaño, L.; de Nanclares, G.P. Two cases of deletion 2q37associated with segregation of an unbalanced translocation 2;21:Choanal atresia leading to misdiagnosis of CHARGE syndrome.Eur. J. Endocrinol., 2009, 160, 711-717.
48. Al-Attia, H.M.; Sedaghatian, M.R. Mental retardation/shortnessof stature/multiple minor anomalies syndrome associated withinsertion of 3q material into 18p. Am. J. Med. Genet., 1995, 56,35-38.
49. McClure, R.J.; Telford, N.; Newell, S.J. A mild phenotypeassociated with der(9)t(3;9) (p25;p23). J. Med. Genet., 1996, 33,625-627.
50. Bittel, D.C.; Kibiryeva, N.; Dasouki, M.; Knoll, J.H.; Butler, M.G. A 9-year-old male with a duplication of chromosome3p25.3p26.2: clinical report and gene expression analysis. Am. J.Med. Genet. A, 2006, 140, 573-579.
51. Borg, K.; Stankiewicz, P.; Bocian, E.; Kruczek, A.; Obersztyn, E.; Lupski, J.R.; Mazurczak, T. Molecular analysis of aconstitutional complex genome rearrangement with 11breakpoints involving chromosomes 3, 11, 12, and 21 and aapproximately 0.5-Mb submicroscopic deletion in a patient withmild mental retardation. Hum. Genet., 2005, 118, 267-275.
52. Blackett, P.R.; Li, S. Mulvihill, J.J. Ring chromosome 4 in apatient with early onset type 2 diabetes, deafness, anddevelopmental delay. Am. J. Med. Genet. A, 2005, 137, 213-216.
53. Bonnet, C.; Zix, C.; Grégoire, M.J.; Brochet, K.; Duc, M.; Rousselet, F.; Philippe, C.; Jonveaux, P. Characterization ofmosaic supernumerary ring chromosomes by array-CGH:segmental aneusomy for proximal 4q in a child with tall statureand obesity. Am. J. Med. Genet. A, 2006, 140, 233-237.
54. van Haelst, M.M.; Wang, R.; Kantaputra, P.N.; Palmer, R.; Beales, P.Obesity syndrome, MOMES caused by deletion-duplication (4q35.1del and 5p14.3 dup). Am. J. Med. Genet. A, 2009, 149A, 833-834.
55. Tzschach, A.; Menzel, C.; Erdogan, F.; Istifli, E.S.; Rieger, M.; Ovens-Raeder, A.; Macke, A.; Ropers, H.H.; Ullmann, R.; Kalscheuer, V. Characterization of an interstitial 4q32 deletion in apatient with mental retardation and a complex chromosomerearrangement. Am. J. Med. Genet. A, 2010, 152A, 1008-1012.
56. Fryns, J.P.; Kleczkowska, A.; Smeets, E.; Thiry, P.; Geutjens, J.; Vanden Berghe, H. Cohen syndrome and de novo reciprocal translocationt(5;7)(q33.1;p15.1). Am. J. Med. Genet., 1990, 37(4), 546-547.
57. Oexle, K.; Hempel, M.; Jauch, A.; Meitinger, T.; Rivera-Brugués, N.; Stengel-Rutkowski, S.; Strom, T. 3.7 Mb tandem microduplication inchromosome 5p13.1-p13.2 associated with developmental delay,macrocephaly, obesity, and lymphedema. Further characterization ofthe dup(5p13) syndrome. Eur. J. Med. Genet., 2011, [epub ahead ofprint].
58. Fryns, J.P.; Bettens, W.; Van den Berghe, H. Distal deletion of thelong arm of chromosome 6: A specific phenotype? Am. J. Med.Genet., 1986, 1, 175-178.
59. Roland, B.; Lowry, R.B.; Cox, D.M.; Ferreira, P.; Lin, C.C. Familialcomplex chromosomal rearrangement resulting induplication/deletion of 6q14 to 6q16. Clin. Genet., 1993, 43(3), 117-121.
60. Villa, A.; Urioste, M.; Bofarull, J.M.; Martínez-Frías, M.L. De novointerstitial deletion q16.2q21 on chromosome 6. Am. J. Med. Genet.,1995, 55, 379-383.
61. Stein, C.K.; Stred, S.E.; Thomson, L.L.; Smith, F.C.; Hoo, J. J. Interstitial 6q deletion and Prader-Willi-like phenotype. Clin. Genet.,1996, 49, 306-310.
62. Smith, A.; Jauch, A.; Slater, H.; Robson, L.; Sandanam, T. Syndromal obesity due to paternal duplication 6(q24.3-q27). Am. J.Med. Genet., 1999, 84, 125-131.
63. Gilhuis, H.J.; van Ravenswaaij, C.M.; Hamel, B.J.; Gabreëls, F.J. Interstitial 6q deletion with a Prader-Willi-like phenotype: A newcase and review of the literature. Eur. J. Paediatr. Neurol., 2000, 4,39-43.
64. Holder, J.L Jr.; Butte, N.F.; Zinn, A.R. Profound obesity associatedwith a balanced translocation that disrupts the SIM1 gene. Hum. Mol.Genet., 2000, 9, 101-108.
65. Faivre, L.; Cormier-Daire, V.; Lapierre, J.M.; Colleaux, L.; Jacquemont, S.; Geneviéve, D.; Saunier, P.; Munnich, A.; Turleau, C.; Romana, S.; Prieur, M.; De Blois, M.C.; Vekemans, M. Deletionof the SIM1 gene (6q16.2) in a patient with a Prader-Willi-likephenotype. J. Med. Genet., 2002, 39, 594-596.
66. Lespinasse, J.; Bugge, M.; Réthoré, M.O.; North, M.O.; Lundsteen, C.; Kirchhoff, M. De novo complex chromosomal rearrangements(CCR) involving chromosome 1, 5, and 6 resulting in microdeletionfor 6q14 in a female carrier with psychotic disorder. Am. J. Med.Genet. A, 2004, 128A, 199-203.
67. Varela, M.C.; Simões-Sato, A.Y.; Kim, C.A.; Bertola, D.R.; DeCastro, C.I.; Koiffmann, C.P. A new case of interstitial 6q16.2deletion in a patient with Prader-Willi-like phenotype andinvestigation of SIM1 gene deletion in 87 patients with syndromicobesity. Eur. J. Med. Genet., 2006, 49, 298-305.
68. Wang, J.C.; Turner, L.; Lomax, B.; Eydoux, P. A 5-Mb microdeletionat 6q16.1-q16.3 with SIM gene deletion and obesity. Am. J. Med.Genet. A, 2008, 146A, 2975-2978.
69. Bonaglia, M.C.; Ciccone, R.; Gimelli, G.; Gimelli, S.; Marelli, S.; erheij, J.; Giorda, R.; Grasso, R.; Borgatti, R.; Pagone, F; Rodrìguez, L.; Martinez-Frias, M.L.; van Ravenswaaij, C.; Zuffardi, O. Detailed phenotype-genotype study in five patients withchromosome 6q16 deletion: Narrowing the critical region for Prader-Willi-like phenotype. Eur. J. Hum. Genet., 2008, 16, 1443-1449.
70. Spreiz, A.; Müller, D.; Zotter, S.; Albrecht, U.; Baumann, M.; Fauth, C.; Erdel, M.; Zschocke, J.; Utermann, G.; Kotzot, D. Phenotypicvariability of a deletion and duplication 6q16.1->q21 due to apaternal balanced ins(7;6)(p15;q16.1q21). Am. J. Med. Genet. A,2010, 152A, 2762-2767.
71. Wentzel, C.; Lynch, S.A.; Stattin, E.L.; Sharkey, F.H.; Annerén, G.; Thuresson, A.C. Interstitial deletions at 6q14.1-q15 associated withobesity, developmental delay and a distinct clinical phenotype. Mol.Syndromol., 2010, 1, 75-81.
72. Frints, S.G.; Schrander-Stumpel, C.T.; Schoenmakers, E.F.; Engelen, J.J.; Reekers, A.B.; Van den Neucker, A.M.; Smeets, E.; Devlieger, H.; Fryns, J.P. Strong variable clinical presentation in 3 patientswith 7q terminal deletion. Genet. Couns., 1998, 9, 5-14.
73. Kozma, C.; Haddad, B.R.; Meck, J.M. Trisomy 7p resulting from7p15;9p24 translocation: Report of a new case and review ofassociated medical complications. Am. J. Med. Genet., 2000, 91,286-290.
74. Kleefstra, T.; van de Zande, G.; Merkx, G.; Mieloo, H.; Hoovers, J.M.; Smeets, D. Identification of an unbalanced cryptictranslocation between the chromosomes 8 and 13 in two sisterswith mild mental retardation accompanied by mild dysmorphicfeatures. Eur. J. Hum. Genet., 2000, 8, 637-640.
75. Menten, B.; Buysse, K.; Vandesompele, J.; De Smet, E.; DePaepe, A.; Speleman, F.; Mortier, G. Identification of anunbalanced X-autosome translocation by array CGH in a boywith a syndromic form of chondrodysplasia punctatabrachytelephalangic type. Eur. J. Med. Genet., 2005, 48, 301-309.
76. Serra, A.; Bova, R.; Bellanova, G.; Chindemi, A.; Zappata, S.; Brahe, C. Partial 9p monosomy in a girl with a tdic(9p23;13p11)translocation, minor anomalies, obesity, and mental retardation.Am. J. Med. Genet., 1997, 71, 139-143.
77. Cormier-Daire, V.; Molinari, F.; Rio, M.; Raoul, O.; de Blois, M.C.; Romana, S.; Vekemans, M.; Munnich, A.; Colleaux, L. Cryptic terminal deletion of chromosome 9q34: a novel cause ofsyndromic obesity in childhood? J. Med. Genet., 2003, 40, 300-303.
78. Neas, K.R.; Smith, J.M.; Chia, N.; Huseyin, S.; St Heaps, L.; Peters, G.; Sholler, G.; Tzioumi, D.; Sillence, D.O.; Mowat, D.Three patients with terminal deletions within the subtelomericregion of chromosome 9q. Am. J. Med. Genet. A, 2005, 132, 425-430.
79. Gawlik-Kuklinska, K.; Iliszko, M.; Wozniak, A.; Debiec-Rychter, M.; Kardas, I.; Wierzba, J.; Limon, J. A girl withduplication 9q34 syndrome. Am. J. Med. Genet. A, 2007, 143A,2019-2023.
80. Gül, D.; Oǧur, G.; Tunca, Y.; Ozcan, O. Third case of WAGRsyndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14). Am. J. Med. Genet., 2002, 107, 70-71.
81. Jung, R.; Rauch, A.; Salomons, G.S.; Verhoeven, N.M.; Jakobs, C.; Michael Gibson, K.; Lachmann, E.; Sass, J.O.; Trautmann, U.; Zweier, C.; Staatz, G.; Knerr, I. Clinical, cytogenetic andmolecular characterization of a patient with combined succinicsemialdehyde dehydrogenase deficiency and incomplete WAGRsyndrome with obesity. Mol. Genet. Metab., 2006, 88, 256-260.
82. Brémond-Gignac, D.; Crolla, J.A.; Copin, H.; Guichet, A.; Bonneau, D.; Taine, L.; Lacombe, D.; Baumann, C.; Benzacken, B.; Verloes, A. Combination of WAGR and Potocki-Shaffercontiguous deletion syndromes in a patient with an 11p11.2-p14deletion. Eur. J. Hum. Genet., 2005, 13, 409-413.
83. Lennon, P.A.; Scott, D.A.; Lonsdorf, D.; Wargowski, D.S.; Kirkpatrick, S.; Patel, A.; Cheung, S.W. WAGR(O?) syndromeand congenital ptosis caused by an unbalancedt(11;15)(p13;p11.2)dn demonstrating a 7 megabase deletion byFISH. Am. J. Med. Genet. A, 2006, 140, 1214-1218.
84. Ausems, M.G.; Schuil, J.; Van Raveswaaij-Arts, C.; De Pater,J.M. Clinical and molecular cytogenetic studies in a case withpartial trisomy 12p due to a de novo supernumerary ringchromosome. Genet. Couns., 2004, 15, 405-410.
85. Niyazov, D.M.; Nawaz, Z.; Justice, A.N.; Toriello, H.V.; Martin, C.L.; Adam, M.P. Genotype/phenotype correlations in twopatients with 12q subtelomere deletions. Am. J. Med. Genet. A, 2007, 143A, 2700-2705.
86. Lemire, E.G.; Cardwell, S. Unusual phenotype in partial trisomy14. Am. J. Med. Genet., 1999, 87, 294-296.
87. Zechner, U.; Kohlschmidt, N.; Rittner, G.; Damatova, N.; Beyer, V.; Haaf, T.; Bartsch, O. Epimutation at human chromosome14q32.2 in a boy with a upd(14)mat-like clinical phenotype.Clin. Genet., 2009, 75, 251-258.
88. Klar, J.; Asling, B.; Carlsson, B.; Ulvsbäck, M.; Dellsén, A.; Ström, C.; Rhedin, M.; Forslund, A.; Annerén, G.; Ludvigsson, J.F.; Dahl, N. RAR-related orphan receptor A isoform 1 (RORa1) isdisrupted by a balanced translocation t(4;15)(q22.3;q21.3) associatedwith severe obesity. Eur. J. Hum. Genet., 2005, 13, 928-934.
89. Chen, Y.; Liu, Y.J.; Pei, Y.F.; Yang, T.L.; Deng, F.Y.; Liu, X.G.; Li, D.Y.; Deng, H.W. Copy number variations at the Prader-Willisyndrome region on chromosome 15 and associations with obesity in Whites. Obesity (Silver Spring), 2011, [Epub ahead of print].
90. Stratakis, C.A.; Lafferty, A.; Taymans, S.E.; Gafni, R.I.; Meck, J.M.; Blancato, J. Anisomastia associated with interstitial duplication ofchromosome 16, mentalretardation, obesity, dysmorphic facies, anddigital anomalies: Molecular mapping of a new syndrome byfluorescent in situ hybridization and microsatellites to16q13(D16S419-D16S503). J. Clin. Endocrinol. Metab., 2000, 85, 3396-3401.
91. van den Berg, L.; de Waal, H.D.; Han, J.C.; Ylstra, B.; Eijk, P.; Nesterova, M.; Heutink, P.; Stratakis, C.A. Investigation of a patientwith a partial trisomy 16q including the fat mass and obesityassociated gene (FTO): fine mapping and FTO gene expression study.Am. J. Med. Genet. A, 2010, 152A, 630-637.
92. Rosenberg, C.; Borovik, C.L.; Canonaco, R.S.; Sichero, L.C.; Queiroz, A.P.; Vianna-Morgante, A.M. Identification of asupernumerary marker derived from chromosome 17 using FISH. Am. J. Med. Genet., 1995, 59, 33-35.
93. Wilson, G.N.; Al Saadi, A.A. Obesity and abnormal behaviourassociated with interstitial deletion of chromosome 18 (q12.2q21.1).J. Med. Genet., 1989, 26, 62-63.
94. Cody, J.D.; Reveles, X.T.; Hale, D.E.; Lehman, D.; Coon, H.; Leach, R.J. Haplosufficiency of the melancortin-4 receptor gene inindividuals with deletions of 18q. Hum. Genet., 1999, 105, 424-427.
95. Swingle, H.M.; Ringdahl, J.; Mraz, R.; Patil, S.; Keppler-Noreuil, K. Behavioral management of a long-term survivor with tetrasomy 18p. Am. J. Med. Genet. A, 2006, 140, 276-280.
96. Zung, A.; Rienstein, S.; Rosensaft, J.; Aviram-Goldring, A.; Zadik, Z. Proximal 19q trisomy: A new syndrome of morbid obesity andmental retardation. Horm. Res., 2007, 67, 105-110.
97. Van der Aa, N.; Vandeweyer, G.; Kooy, R.F. A boy with mentalretardation, obesity and hypertrichosis caused by a microdeletion of19p13.12. Eur. J. Med. Genet., 2010, 53, 291-293.
98. Davidsson, J.; Jahnke, K.; Forsgren, M.; Collin, A.; Soller, M. Dup(19)(q12q13.2): Array-based genotype-phenotype correlation of anew possibly obesity-related syndrome. Obesity (Silver Spring),2010, 18, 580-587.
99. Aldred, M.A.; Aftimos, S.; Hall, C.; Waters, K.S.; Thakker, R.V.; Trembath, R.C.; Brueton, L. Constitutional deletion of chromosome20q in two patients affected with albright hereditary osteodystrophy.Am. J. Med. Genet., 2002, 113, 167-172.
100. Braddock, S.R.; Henley, K.M.; Potter, K.L.; Nguyen, H.G.; Huang, T.H. Tertiary trisomy due to a reciprocal translocation ofchromosomes 5 and 21 in a four-generation family. Am. J. Med.Genet., 2000, 92, 311-317.
101. D'Angelo, C.S.; Jehee, F.S.; Koiffmann, C.P. An inherited atypical 1Mb 22q11.2 deletion within the DGS/VCFS 3 Mb region in a childwith obesity and aggressive behavior. Am. J. Med. Genet. A, 2007,143A, 1928-1932.
102. Digilio, M.C.; Marino, B.; Cappa, M.; Cambiaso, P.; Giannotti, A.; Dallapiccola, B. Auxological evaluation in patients withDiGeorge/velocardiofacial syndrome (deletion 22q11.2 syndrome).Genet. Med., 2001, 3, 30-33.
103. Michaud, J.L.; Rosenquist, T.; May, N.R.; Fan, C.M. Development ofneuroendocrine lineages requires the bHLH-PAS transcription factorSIM1. Genes & Dev., 1998, 12, 3264-3275.
104. Michaud, J. L., Boucher, F., Melnyk, A., Gauthier, F., Goshu, E., Levy, E., Mitchell, G. A., Himms-Hagen, J., Fan, C.M. Sim1haploinsufficiency causes hyperphagia, obesity and reduction of theparaventricular nucleus of the hypothalamus. Hum. Mol. Genet.,2001, 10, 1465-1473.
105. Tolson, K.P.; Gemelli, T.; Gautron, L.; Elmquist, J.K.; Zinn, A.R.; Kublaoui, B.M. Postnatal Sim1 deficiency causes hyperphagicobesity and reduced Mc4r and oxytocin expression. J. Neurosci.,2010, 30, 3803-3812.